Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection
暂无分享，去创建一个
James D. Allen | M. Diamond | J. Crowe | M. Mack | Seth J. Zost | R. Head | T. Ross | Hyesun Jang | P. Gilchuk | A. Boon | Jinsheng Yu | J. Case | Rita E. Chen | Emma S. Winkler | R. Carnahan | Ying Huang | Adam Leitman Bailey | Rachel E. Sutton | T. Darling | J. Allen